Evidence map›Paper›PMID 27822484›Full record

ArticleJournal of immunology research2016

Impact of Ivabradine on Inflammatory Markers in Chronic Heart Failure.

Ilonka Rohm, Daniel Kretzschmar, Rudin Pistulli, Marcus Franz, P Christian Schulze, Christian Stumpf, Atilla Yilmaz

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of immunology research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. New Targets in Heart Failure Drug Therapy.Frontiers in cardiovascular medicine · 2021
    Review
  8. Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Ilonka RohmDepartment of Internal Medicine I, Friedrich-Schiller-University of Jena, Jena, Germany.ORCID 0000-0002-7727-8356
Daniel KretzschmarDepartment of Internal Medicine I, Friedrich-Schiller-University of Jena, Jena, Germany.
Rudin PistulliDepartment of Internal Medicine I, Friedrich-Schiller-University of Jena, Jena, Germany.
Marcus FranzDepartment of Internal Medicine I, Friedrich-Schiller-University of Jena, Jena, Germany.ORCID 0000-0001-6543-4684
P Christian SchulzeDepartment of Internal Medicine I, Friedrich-Schiller-University of Jena, Jena, Germany.
Christian StumpfDepartment of Internal Medicine II, Friedrich-Alexander University of Erlangen-Nuremberg, Erlangen, Germany.
Atilla YilmazDepartment of Internal Medicine II, Elisabeth Klinikum Schmalkalden, Schmalkalden, Germany.
Friedrich Schiller University Jena · DEFriedrich-Alexander-Universität Erlangen-Nürnberg · DESchmalkalden University of Applied Sciences · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Adrenergic beta-AntagonistsAdultAgedBenzazepinesBiomarkersCardiovascular AgentsChronic DiseaseComorbidityCytokinesEchocardiographyFemaleFollow-Up StudiesHeart FailureHumansInflammation MediatorsIvabradineAdrenergic beta-AntagonistsBenzazepinesBiomarkersCardiovascular AgentsCytokinesInflammation MediatorsIvabradine

Identifiers

PMID27822484
PMCPMC5086393
OpenAlexW2531740240

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.